Bleeding Risk Following Stereotactic Body Radiation Therapy for Localized Prostate Cancer in Men on Baseline Anticoagulant or Antiplatelet Therapy

PURPOSE: Patients on anticoagulant/antiplatelet medications are at a high risk of bleeding following external beam radiation therapy for localized prostate cancer. SBRT may reduce the bleeding risk by decreasing the volume of bladder/rectum receiving high doses. This retrospective study sought to ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Pepin, Abigail, Shah, Sarthak, Pernia, Monica, Lei, Siyuan, Ayoob, Marilyn, Danner, Malika, Yung, Thomas, Collins, Brian T., Suy, Simeng, Aghdam, Nima, Collins, Sean P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485025/
https://www.ncbi.nlm.nih.gov/pubmed/34604059
http://dx.doi.org/10.3389/fonc.2021.722852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485025/
https://www.ncbi.nlm.nih.gov/pubmed/34604059
http://dx.doi.org/10.3389/fonc.2021.722852

Ejemplares similares